Latest news and insights on the pharmaceutical industry | Indian Pharma Post | Page 2

Results For "RI"

10069 News Found

CSIR-HRDC hosts intensive workshop on AI-driven drug discovery for scientists
Digitisation | April 10, 2026

CSIR-HRDC hosts intensive workshop on AI-driven drug discovery for scientists

Three-day programme equips CSIR researchers with advanced AI tools, molecular docking insights, and biomolecular simulation expertise


Bayer sets world record for maternal nutrition advocacy
Healthcare | April 09, 2026

Bayer sets world record for maternal nutrition advocacy

India continues to face a major maternal nutrition challenge, with nearly 60% of women affected by anaemia and more than 70% experiencing calcium deficiency


Govt. of Madhya Pradesh, mlHealth360 launch AI radiology pilot in 10 district hospitals
Digitisation | April 09, 2026

Govt. of Madhya Pradesh, mlHealth360 launch AI radiology pilot in 10 district hospitals

At the center of deployment is mlHealth360’s proprietary Scaida AI platform, designed to detect and triage abnormalities in CT scans


Chiba University study flags allergy risk in high-binding antibody drugs
Biopharma | April 09, 2026

Chiba University study flags allergy risk in high-binding antibody drugs

For the biopharma industry, the study strengthens the case for balancing immune-cell engagement with tolerability in antibody discovery platforms


Glenmark gets USFDA approval for generic Endometrin vaginal inserts
Drug Approval | April 09, 2026

Glenmark gets USFDA approval for generic Endometrin vaginal inserts

Final approval for progesterone vaginal inserts expands Glenmark’s women’s healthcare portfolio in the US, targeting a market of over $59 million


India’s Dapagliflozin Moment: Why USFDA’s generic greenlight wave matters
Drug Approval | April 09, 2026

India’s Dapagliflozin Moment: Why USFDA’s generic greenlight wave matters

In just the last few days, companies including Lupin, Biocon, Alembic Pharmaceuticals and Aurobindo Pharma have announced approvals for 5 mg and 10 mg tablets, all bioequivalent to Farxiga


Halozyme strikes global deal with Vertex to expand Hypercon drug delivery technology
Technology | April 09, 2026

Halozyme strikes global deal with Vertex to expand Hypercon drug delivery technology

The deal gives Vertex access to Halozyme’s Hypercon technology for up to three drug targets


Johnson & Johnson unveils Varipulse Pro in Europe for faster & safer heart procedures
News | April 09, 2026

Johnson & Johnson unveils Varipulse Pro in Europe for faster & safer heart procedures

The new device promises faster, more efficient cardiac procedures while maintaining the safety and effectiveness clinicians expect


Solara Active Pharma dispatches final rights share call notice; Rs 112.5 per share due by May 7
News | April 08, 2026

Solara Active Pharma dispatches final rights share call notice; Rs 112.5 per share due by May 7

API maker begins circulation of second and final call money notice for partly paid-up rights shares, completing the last leg of its 2024 fundraising cycle


Trialt and Viedoc team up to transform clinical trials
Clinical Trials | April 08, 2026

Trialt and Viedoc team up to transform clinical trials

The partnership aims to accelerate clinical trial timelines, boost data quality, and improve decision-making for sponsors worldwide